• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Convalescent plasma for patients with COVID-19.

作者信息

Zeng Furong, Chen Xiang, Deng Guangtong

机构信息

Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

Xiangya Hospital, Central South University, Changsha, Hunan 410008, China

出版信息

Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12528. doi: 10.1073/pnas.2006961117. Epub 2020 May 12.

DOI:10.1073/pnas.2006961117
PMID:32398379
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7293648/
Abstract
摘要

相似文献

1
Convalescent plasma for patients with COVID-19.新冠康复者血浆用于新冠肺炎患者。
Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12528. doi: 10.1073/pnas.2006961117. Epub 2020 May 12.
2
Why should we use convalescent plasma for COVID-19?我们为什么要将康复期血浆用于治疗新冠肺炎？
Eur J Intern Med. 2020 Jul;77:150-151. doi: 10.1016/j.ejim.2020.05.019. Epub 2020 May 16.
3
Convalescent plasma for covid-19.用于治疗新冠病毒肺炎的康复期血浆
BMJ. 2020 Sep 15;370:m3516. doi: 10.1136/bmj.m3516.
4
[Use of convalescent plasma for COVID-19 treatment. History and evidence].[康复期血浆用于新型冠状病毒肺炎治疗。历史与证据]
Medicina (B Aires). 2020;80 Suppl 3:82-86.
5
Convalescent Plasma and COVID-19.康复期血浆与2019冠状病毒病
JAMA. 2020 Aug 4;324(5):524. doi: 10.1001/jama.2020.10699.
6
Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19?从康复期血浆制备的同种疗法药物能否作为治疗 COVID-19 的一种选择？
Homeopathy. 2020 Aug;109(3):184-185. doi: 10.1055/s-0040-1714061. Epub 2020 Jul 9.
7
Challenges of Convalescent Plasma Therapy on COVID-19.恢复期血浆疗法治疗新冠病毒肺炎面临的挑战
J Clin Virol. 2020 Jun;127:104358. doi: 10.1016/j.jcv.2020.104358. Epub 2020 Apr 10.
8
A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals.一项关于新冠康复期血浆治疗的随机试验——潜在的希望信号
JAMA. 2020 Aug 4;324(5):455-457. doi: 10.1001/jama.2020.10218.
9
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
10
Convalescent plasma is ineffective for covid-19.康复期血浆对新冠病毒肺炎无效。
BMJ. 2020 Oct 22;371:m4072. doi: 10.1136/bmj.m4072.

引用本文的文献

1
Immunization technologies: Time to consider new preventative solutions for respiratory syncytial virus infections.免疫技术：是时候考虑针对呼吸道合胞病毒感染的新预防解决方案了。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2209000. doi: 10.1080/21645515.2023.2209000.
2
Clinical nursing care protocol for convalescent plasma transfusion in patients with COVID-19.新型冠状病毒肺炎患者恢复期血浆输注的临床护理方案
Int J Afr Nurs Sci. 2023;18:100518. doi: 10.1016/j.ijans.2022.100518. Epub 2022 Dec 13.
3
Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipation.分析 52240 名恢复期 COVID-19 血浆供体的源血浆：初始抗体水平和衰减率与性别、种族和年龄的关系。
J Clin Apher. 2022 Oct;37(5):449-459. doi: 10.1002/jca.21998. Epub 2022 Jul 11.
4
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.新型冠状病毒肺炎被动免疫治疗的最新进展：基于证据的方法和临床试验。
Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21.
5
Perplexing issues for convalescent immune plasma therapy in COVID-19.新冠康复期免疫血浆疗法面临的棘手问题。
North Clin Istanb. 2021 Nov 15;8(6):634-643. doi: 10.14744/nci.2021.73604. eCollection 2021.
6
Polyclonal F(ab') fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency.针对刺突蛋白产生的马源抗体的多克隆F(ab')片段能高效中和SARS-CoV-2变体。
iScience. 2021 Nov 19;24(11):103315. doi: 10.1016/j.isci.2021.103315. Epub 2021 Oct 23.
7
Effect of time and titer in convalescent plasma therapy for COVID-19.时间和滴度在COVID-19恢复期血浆治疗中的作用。
iScience. 2021 Aug 20;24(8):102898. doi: 10.1016/j.isci.2021.102898. Epub 2021 Jul 22.
8
A Narrative Review of a Pulmonary Aerosolized Formulation or a Nasal Drop Using Sera Containing Neutralizing Antibodies Collected from COVID-19-Recovered Patients as a Probable Therapy for COVID-19.对含有从 COVID-19 康复患者中采集的中和抗体的血清制成的肺部雾化制剂或鼻腔滴剂作为 COVID-19 可能疗法的综述。
Iran J Med Sci. 2021 May;46(3):151-168. doi: 10.30476/ijms.2020.86417.1624.
9
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.恢复期血浆用于 COVID-19 的预防和治疗：系统评价和定量分析。
JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.
10
Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.高通量筛选数据库的挖掘揭示了 AP-1 和自噬途径可能成为 COVID-19 治疗的靶点。
Sci Rep. 2021 Mar 24;11(1):6725. doi: 10.1038/s41598-021-86110-8.

本文引用的文献

1
Effectiveness of convalescent plasma therapy in severe COVID-19 patients.恢复期血浆疗法治疗重症 COVID-19 患者的疗效。
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.
2
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.5 例危重症 COVID-19 患者接受恢复期血浆治疗。
JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.
3
Management of Critically Ill Adults With COVID-19.新型冠状病毒肺炎危重症成人患者的管理
JAMA. 2020 May 12;323(18):1839-1841. doi: 10.1001/jama.2020.4914.
4
Convalescent plasma as a potential therapy for COVID-19.康复期血浆作为治疗新冠肺炎的一种潜在疗法。
Lancet Infect Dis. 2020 Apr;20(4):398-400. doi: 10.1016/S1473-3099(20)30141-9. Epub 2020 Feb 27.
5
Plasma treated with methylene blue and light: clinical efficacy and safety profile.亚甲蓝联合光处理的血浆：临床疗效和安全性特征。
Transfus Med Rev. 2013 Oct;27(4):235-40. doi: 10.1016/j.tmrv.2013.08.001. Epub 2013 Sep 24.